Published in Invest Ophthalmol Vis Sci on February 01, 2004
Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina (2007) 1.83
Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye (Lond) (2013) 1.56
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov (2012) 1.52
Intravitreal injection of AAV2 transduces macaque inner retina. Invest Ophthalmol Vis Sci (2011) 1.46
Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc (2005) 1.26
Ocriplasmin for vitreoretinal diseases. J Biomed Biotechnol (2012) 1.06
Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol (2006) 1.01
Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review. Clin Ophthalmol (2011) 1.00
Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels. Exp Eye Res (2008) 0.93
Proteomic interactions in the mouse vitreous-retina complex. PLoS One (2013) 0.88
Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Retina (2011) 0.88
Ocriplasmin for treatment of stage 2 macular holes: early clinical results. Ophthalmic Surg Lasers Imaging Retina (2014) 0.87
Retinal breaks due to intravitreal ocriplasmin. Clin Ophthalmol (2014) 0.86
Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion. Clin Ophthalmol (2014) 0.85
Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole. Graefes Arch Clin Exp Ophthalmol (2014) 0.81
Retinal Changes Induced by Epiretinal Tangential Forces. J Ophthalmol (2015) 0.80
Optimal management of idiopathic macular holes. Clin Ophthalmol (2016) 0.80
Laser, intravitreal drug application, and surgery to treat diabetic eye disease. Oman J Ophthalmol (2013) 0.79
[Pharmacological vitreolysis]. Ophthalmologe (2013) 0.79
Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential. Core Evid (2014) 0.76
Prevalence of vitreomacular adhesion: an optical coherence tomography analysis in the retina clinic setting. Clin Ophthalmol (2016) 0.75
Ocriplasmin: who is the best candidate? Clin Ophthalmol (2016) 0.75
Quantitative imaging of enzymatic vitreolysis-induced fiber remodeling. Invest Ophthalmol Vis Sci (2014) 0.75
Rhegmatogenous retinal detachment following intravitreal ocriplasmin. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
High osmolarity effect of intravitreal plasmin enzyme on rabbit retina. Nagoya J Med Sci (2015) 0.75
Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment. Indian J Ophthalmol (2016) 0.75
Lamellar macular hole after intravitreal ocriplasmin injection. BMJ Case Rep (2015) 0.75
Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
[The primary objective in macular hole surgery. Ultrastructural features of the vitreomacular interface]. Ophthalmologe (2007) 0.75
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina (2006) 3.09
Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol (2002) 2.95
Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg (2013) 2.12
Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial. Ophthalmology (2009) 1.90
Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet (2009) 1.83
The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol (2003) 1.74
Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases. Am J Ophthalmol (2006) 1.66
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A (2007) 1.62
Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up. Graefes Arch Clin Exp Ophthalmol (2010) 1.57
Long-term functional outcome of macular hole surgery correlated to optical coherence tomography measurements. Clin Experiment Ophthalmol (2007) 1.56
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology (2002) 1.52
Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol (2009) 1.52
Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci (2003) 1.50
Intravitreal bevacizumab (Avastin) treatment is safe in terms of intraocular and blood pressure. Acta Ophthalmol Scand (2007) 1.49
Real-time intraocular pressure measurement in standard and microcoaxial phacoemulsification. J Cataract Refract Surg (2010) 1.48
The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol (2010) 1.45
Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol (2002) 1.45
Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol (2007) 1.45
Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol (2003) 1.42
Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol (2002) 1.41
A qualitative study in the United Kingdom of factors influencing attendance by patients with diabetes at ophthalmic outpatient clinics. Ophthalmic Epidemiol (2007) 1.40
Multi-MHz retinal OCT. Biomed Opt Express (2013) 1.36
Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol (2003) 1.33
Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet (2012) 1.33
Retinal pigment epithelium is protected against apoptosis by alphaB-crystallin. Invest Ophthalmol Vis Sci (2002) 1.30
Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina (2007) 1.28
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol (2004) 1.26
Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2007) 1.26
Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp Eye Res (2009) 1.22
Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin. Ophthalmology (2004) 1.17
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev (2013) 1.17
Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci (2004) 1.17
Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol (2005) 1.15
In vivo confocal microscopy of corneal small fiber damage in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol (2010) 1.14
Evaluation of a novel Scheimpflug-based non-contact tonometer in healthy subjects and patients with ocular hypertension and glaucoma. Br J Ophthalmol (2013) 1.13
The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci (2008) 1.12
Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol (2003) 1.11
Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens. Retina (2013) 1.11
Residual cellular proliferation on the internal limiting membrane in macular pucker surgery. Retina (2012) 1.10
Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Exp Eye Res (2004) 1.09
S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem (2009) 1.08
Indications and clinical outcome of capsular tension ring (CTR) implantation: A review of 9528 cataract surgeries. Clin Ophthalmol (2007) 1.06
Five-year follow-up of macular hole surgery with peeling of the internal limiting membrane: update of a prospective study. Retina (2006) 1.05
Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol (2010) 1.05
Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. Invest Ophthalmol Vis Sci (2008) 1.05
A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol (2007) 1.04
Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci (2003) 1.04
Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care (2012) 1.04
Vital dyes for macular surgery: a comparative electron microscopy study of the internal limiting membrane. Retina (2009) 1.03
Visual quality of life after macular hole surgery: outcome and predictive factors. Br J Ophthalmol (2006) 1.03
Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol (2013) 1.02
Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap). Clin Ophthalmol (2010) 1.02
Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas). Clin Ophthalmol (2012) 1.01
Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 1.01
Immunocytochemical and ultrastructural evidence of glial cells and hyalocytes in internal limiting membrane specimens of idiopathic macular holes. Invest Ophthalmol Vis Sci (2011) 1.01
In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg (2008) 1.01
The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. Invest Ophthalmol Vis Sci (2009) 1.01
Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research. Graefes Arch Clin Exp Ophthalmol (2014) 1.01
Peripheral fundus autofluorescence is increased in age-related macular degeneration. Invest Ophthalmol Vis Sci (2012) 1.01
Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in Germany: Model analysis from the perspective of Germany's statutory health insurance system. Clin Ther (2010) 1.01
Epiretinal membrane characteristics correlate with photoreceptor layer defects in lamellar macular holes and macular pseudoholes. Retina (2015) 1.00
Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci (2006) 1.00
Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium. Invest Ophthalmol Vis Sci (2003) 0.99
In vivo confocal microscopy of filtering blebs after trabeculectomy. Arch Ophthalmol (2006) 0.99
Focal and panretinal photocoagulation with a navigated laser (NAVILAS®). Acta Ophthalmol (2010) 0.98
Toxicity of indocyanine green in vitreoretinal surgery. Dev Ophthalmol (2008) 0.98
Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Invest Ophthalmol Vis Sci (2009) 0.97
Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Ophthalmologica (2012) 0.97
Wide-field fundus autofluorescence corresponds to visual fields in chorioretinitis patients. Clin Ophthalmol (2011) 0.97
The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment. Invest Ophthalmol Vis Sci (2007) 0.96
The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch Clin Exp Ophthalmol (2009) 0.95
Systematic analysis of wide-field fundus autofluorescence (FAF) imaging in posterior uveitis. Curr Eye Res (2013) 0.95
Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. Retina (2014) 0.95
Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells. Exp Eye Res (2008) 0.95
Filtering blue light reduces light-induced oxidative stress, senescence and accumulation of extracellular matrix proteins in human retinal pigment epithelium cells. Clin Experiment Ophthalmol (2011) 0.95
Morphological and immunohistochemical changes after corneal cross-linking. Cornea (2013) 0.95
Visual loss as a first sign of adult-type chronic myeloid leukemia in a child. Am J Ophthalmol (2005) 0.95
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina (2015) 0.95
Idiopathic macular holes: ultrastructural aspects of surgical failure. Retina (2008) 0.94
Megahertz ultra-wide-field swept-source retina optical coherence tomography compared to current existing imaging devices. Graefes Arch Clin Exp Ophthalmol (2014) 0.94
Distribution of antigen presenting cells in the human cornea: correlation of in vivo confocal microscopy and immunohistochemistry in different pathologic entities. Curr Eye Res (2012) 0.94
An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci (2005) 0.94
Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing cataract surgery. Eur J Ophthalmol (2012) 0.94
Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial. Am J Ophthalmol (2004) 0.93
Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. J Proteome Res (2006) 0.93
Consenting to cornea donation: influencing factors. Graefes Arch Clin Exp Ophthalmol (2002) 0.92
The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project. Ophthalmology (2012) 0.92
Sequential epiretinal membrane removal with internal limiting membrane peeling in brilliant blue G-assisted macular surgery. Br J Ophthalmol (2010) 0.92
Oxidative stress-mediated induction of MMP-1 and MMP-3 in human RPE cells. Invest Ophthalmol Vis Sci (2009) 0.92
Biochemical and morphological analysis of basement membrane component expression in corneoscleral and cribriform human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2006) 0.92
Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center. Retina (2014) 0.92